| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
| Product | 1,408.40 | 1,980.30 | 2,048.10 | 2,035.80 | 1,239.15 | 1,143.74 | 936.41 | 829.87 | 741.32 | 663.85 |
| Royalty and license fee | 118.50 | 114.10 | -- | -- | -- | -- | 1.43 | 28.42 | 56.78 | 30.78 |
| Total Revenues | 1,526.90 | 2,094.40 | 2,048.10 | 2,035.80 | 1,239.15 | 1,143.74 | 937.84 | 858.29 | 798.11 | 694.63 |
| Cost of goods sold | 581.70 | 1,090.00 | 1,044.60 | 977.00 | 430.81 | 400.68 | 308.67 | 283.40 | 263.01 | 230.83 |
| Gross Profit | 945.20 | 1,004.40 | 1,003.50 | 1,058.80 | 808.35 | 743.07 | 629.17 | 574.89 | 535.10 | 463.80 |
| Research and development | 126.40 | 222.80 | 175.20 | 191.40 | 137.23 | 118.66 | 93.30 | 76.97 | 61.95 | 59.36 |
| Selling, general and administrative | 506.00 | 743.80 | 664.00 | 657.40 | 395.29 | 369.06 | 314.66 | 289.46 | 275.79 | 253.67 |
| Impairment charge | -- | (304.00) | (10.00) | -- | -- | -- | -- | -- | -- | -- |
| Antitrust litigation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Litigation award and defense costs | (2.80) | (0.50) | (17.80) | -- | -- | 0.47 | -- | (0.43) | -- | 270.00 |
| Total Operating Expenses | 635.20 | 1,271.10 | 867.00 | 848.80 | 532.53 | 487.24 | 407.96 | 366.85 | 337.74 | 43.03 |
| Operating income (Loss) | 310.00 | (266.70) | 136.50 | 210.00 | 275.82 | 255.82 | 221.22 | 208.04 | 197.36 | 420.77 |
| Interest expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other | -- | -- | -- | -- | -- | -- | 12.95 | -- | -- | -- |
| Non-operating expense | (37.40) | (38.60) | (48.40) | (16.60) | (1.44) | 7.91 | -- | 5.73 | 2.01 | (2.43) |
| Pre-Tax Income - Foreign | -- | -- | -- | 115.80 | 53.16 | 48.92 | -- | -- | 27.81 | 97.64 |
| Pre-Tax Income: United States | -- | -- | -- | 77.60 | 221.23 | 214.82 | -- | -- | 171.56 | 320.70 |
| Income before provision for income taxes | 272.60 | (305.30) | 88.10 | 193.40 | 274.38 | 263.74 | 234.17 | 213.78 | 199.37 | 418.34 |
| Current- Foreign | 25.50 | 19.40 | 23.70 | 34.40 | 14.58 | 8.07 | 8.42 | 5.01 | 3.02 | 5.82 |
| Current: Federal | 23.50 | 15.00 | 15.00 | 48.70 | 38.17 | 13.90 | 30.22 | 20.42 | 38.78 | 99.53 |
| Current: State | 4.10 | 3.40 | 3.50 | 6.10 | 7.07 | 6.44 | 5.27 | 3.08 | 1.94 | 6.92 |
| Provision for income taxes | 64.90 | (0.40) | 6.60 | 49.90 | 44.73 | 23.45 | 37.95 | 20.23 | 67.76 | 117.68 |
| Deferred: Federal | 6.10 | (19.00) | (12.50) | (20.50) | (4.88) | 1.35 | (3.73) | (6.68) | 27.00 | 2.98 |
| Deferred: State | 6.40 | (8.30) | (9.00) | (8.70) | (6.05) | (6.19) | (1.99) | (1.26) | (3.00) | 2.33 |
| Deferred: Foreign | (0.70) | (10.90) | (14.10) | (10.10) | (4.15) | (0.13) | (0.25) | (0.34) | 0.02 | 0.09 |
| Net income from continuing operations, net of tax | 207.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| (Loss) from discontinued operations, net of tax | (359.20) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Consolidated Net Income (Loss) | (151.50) | (304.90) | 81.50 | 143.50 | 229.65 | 240.28 | 196.22 | 193.54 | 131.62 | 300.67 |
| Less- Net income attributable to noncontrolling interests | -- | -- | -- | -- | -- | (0.02) | -- | -- | -- | -- |
| Accretion of preferred stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Undistributed income attributable to preferred stockholders | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | (151.50) | (304.90) | 81.50 | 143.50 | 229.65 | 240.30 | 196.22 | 193.54 | 131.62 | 300.67 |
| Basic income per share - continuing operations | 3.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic (loss) per share - discontinued operations | (6.70) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | (2.83) | (5.72) | 1.54 | 2.68 | 4.16 | 4.39 | 3.67 | 3.70 | 2.55 | 6.07 |
| Diluted income per share - continuing operations | 3.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted (loss) per share - discontinued operations | (6.63) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | (2.80) | (5.72) | 1.51 | 2.60 | 3.98 | 4.14 | 3.44 | 3.45 | 2.36 | 5.65 |
| Weighted Average Shares Outstanding (Basic) | 53.60 | 53.30 | 52.80 | 53.60 | 55.17 | 54.70 | 53.43 | 52.30 | 51.52 | 49.53 |
| Weighted-average number of common shares: Basic - Two class method | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted-average number of common shares: Basic - Single class method | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Outstanding (Diluted) | 54.20 | 53.30 | 54.10 | 55.20 | 57.68 | 58.04 | 57.10 | 56.04 | 55.87 | 53.20 |
| Weighted-average number of common shares: Diluted - Two class method | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted-average number of common shares: Diluted - Single class method | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |